Whereas NFA 18.7.7 had increased effects on a number of different anti-inflammatory signaling pathways, the biological effects of NFA 18.8.8 are mainly restricted to inhibiting NF-κB signaling and inducing cytotoxicity in colorectal cancer cells. This evidence concerns the gene NFKB1 and colorectal cancer.